Search
for
Sort by
Research 451–480 of 1000+
- Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine
- Finasteride versus dutasteride: a real-world economic evaluation.
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment.
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Clascoterone Cream 1% in Acne Management: Case Series and Real-World Canadian Experience
- Adverse events of dual anti-seizure medication: Real-life data from a tertiary epilepsy clinic
- EMT Factors and Metabolic Pathways in Cancer
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Sentinel lymph node in early stage ovarian cancer; a literature review
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Listening to patients: A qualitative study on diagnostic delay, coping strategies and stigma in early‐onset colorectal cancer
- Long-term live imaging of the<i>Drosophila</i>adult midgut reveals real-time dynamics of cell division, differentiation, and loss